Quipt Home Medical Corp. (QIPT)
USD 2.41
(-7.49%)
USD 2.41
(-7.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 136.29 Million USD | 158.78% |
| 2022 | 52.66 Million USD | 5.44% |
| 2021 | 49.95 Million USD | 14.37% |
| 2020 | 43.67 Million CAD | 60.54% |
| 2019 | 27.2 Million CAD | 17.82% |
| 2018 | 23.09 Million CAD | -24.99% |
| 2017 | 30.78 Million CAD | 51.49% |
| 2016 | 20.32 Million CAD | -27.61% |
| 2015 | 28.07 Million CAD | 18.47% |
| 2014 | 23.69 Million CAD | 219.78% |
| 2013 | 7.41 Million CAD | 409.74% |
| 2012 | 1.45 Million CAD | 4.59% |
| 2011 | 1.38 Million CAD | 105.05% |
| 2010 | 677.85 Thousand CAD | 101.23% |
| 2009 | 336.86 Thousand CAD | -87.45% |
| 2008 | 2.68 Million CAD | 22.05% |
| 2007 | 2.19 Million CAD | -7.8% |
| 2006 | 2.38 Million CAD | 15.24% |
| 2005 | 2.06 Million CAD | -13.13% |
| 2004 | 2.38 Million CAD | 74.42% |
| 2003 | 1.36 Million CAD | 7.25% |
| 2002 | 1.27 Million CAD | 52.07% |
| 2001 | 837.24 Thousand CAD | 36.11% |
| 2000 | 615.13 Thousand CAD | 10470.14% |
| 1999 | 5819.55 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 132.61 Million USD | -2.2% |
| 2024 Q2 | 138.12 Million USD | 3.73% |
| 2024 Q3 | 139.96 Million USD | 1.24% |
| 2023 Q2 | 143.74 Million USD | 180.3% |
| 2023 Q1 | 51.28 Million USD | -2.63% |
| 2023 Q3 | 131.4 Million USD | -8.58% |
| 2023 Q4 | 136.29 Million USD | 3.72% |
| 2023 FY | 136.29 Million USD | 158.78% |
| 2022 FY | 52.66 Million USD | 5.44% |
| 2022 Q1 | 48.77 Million USD | -2.36% |
| 2022 Q4 | 52.66 Million USD | -16.07% |
| 2022 Q2 | 44.81 Million USD | -8.11% |
| 2022 Q3 | 62.75 Million USD | 40.02% |
| 2021 Q1 | 49.58 Million USD | 13.52% |
| 2021 FY | 49.95 Million USD | 14.37% |
| 2021 Q4 | 49.95 Million USD | -0.94% |
| 2021 Q3 | 50.42 Million USD | -12.51% |
| 2021 Q2 | 57.63 Million USD | 16.24% |
| 2020 Q4 | 43.67 Million CAD | 16.13% |
| 2020 FY | 43.67 Million CAD | 60.54% |
| 2020 Q3 | 37.6 Million CAD | 22.65% |
| 2020 Q1 | 33.44 Million CAD | 22.93% |
| 2020 Q2 | 30.66 Million CAD | -8.31% |
| 2019 Q2 | 34.11 Million CAD | 53.5% |
| 2019 Q3 | 27.38 Million CAD | -19.73% |
| 2019 Q4 | 27.2 Million CAD | -0.65% |
| 2019 FY | 27.2 Million CAD | 17.82% |
| 2019 Q1 | 22.22 Million CAD | -3.75% |
| 2018 Q3 | 22.21 Million CAD | 2.45% |
| 2018 Q1 | 22.2 Million CAD | -27.87% |
| 2018 FY | 23.09 Million CAD | -24.99% |
| 2018 Q2 | 21.68 Million CAD | -2.34% |
| 2018 Q4 | 23.09 Million CAD | 3.93% |
| 2017 Q1 | 22 Million CAD | 8.28% |
| 2017 Q4 | 30.78 Million CAD | 3.64% |
| 2017 Q3 | 29.7 Million CAD | 10.55% |
| 2017 Q2 | 26.87 Million CAD | 22.11% |
| 2017 FY | 30.78 Million CAD | 51.49% |
| 2016 Q1 | 37.93 Million CAD | 35.14% |
| 2016 Q3 | 30.4 Million CAD | -31.65% |
| 2016 Q4 | 20.32 Million CAD | -33.16% |
| 2016 FY | 20.32 Million CAD | -27.61% |
| 2016 Q2 | 44.48 Million CAD | 17.26% |
| 2015 Q3 | 129.76 Million CAD | 191.06% |
| 2015 Q4 | 28.07 Million CAD | -78.36% |
| 2015 Q2 | 44.58 Million CAD | 95.76% |
| 2015 FY | 28.07 Million CAD | 18.47% |
| 2015 Q1 | 22.77 Million CAD | -3.9% |
| 2014 Q2 | 8.41 Million CAD | 20.81% |
| 2014 Q3 | 10.73 Million CAD | 27.54% |
| 2014 Q4 | 23.69 Million CAD | 120.69% |
| 2014 Q1 | 6.96 Million CAD | -5.96% |
| 2014 FY | 23.69 Million CAD | 219.78% |
| 2013 FY | 7.41 Million CAD | 409.74% |
| 2013 Q1 | 1.44 Million CAD | -0.62% |
| 2013 Q4 | 7.41 Million CAD | 428.92% |
| 2013 Q3 | 1.4 Million CAD | 9.68% |
| 2013 Q2 | 1.27 Million CAD | -11.58% |
| 2012 Q4 | 1.45 Million CAD | -17.24% |
| 2012 FY | 1.45 Million CAD | 4.59% |
| 2012 Q2 | 2.15 Million CAD | -5.88% |
| 2012 Q1 | 2.29 Million CAD | 65.04% |
| 2012 Q3 | 1.75 Million CAD | -18.64% |
| 2011 FY | 1.38 Million CAD | 105.05% |
| 2011 Q4 | 1.38 Million CAD | 24.98% |
| 2011 Q3 | 1.11 Million CAD | 27.01% |
| 2011 Q2 | 875.65 Thousand CAD | 8.18% |
| 2011 Q1 | 809.41 Thousand CAD | 19.41% |
| 2010 Q4 | 677.85 Thousand CAD | 0.0% |
| 2010 Q1 | 239.67 Thousand CAD | -23.87% |
| 2010 FY | 677.85 Thousand CAD | 101.23% |
| 2010 Q2 | 325.35 Thousand CAD | 35.75% |
| 2009 Q2 | 839.97 Thousand CAD | 4.65% |
| 2009 Q3 | 336.86 Thousand CAD | -59.9% |
| 2009 Q1 | 802.61 Thousand CAD | -75.44% |
| 2009 Q4 | 314.79 Thousand CAD | -6.55% |
| 2009 FY | 336.86 Thousand CAD | -87.45% |
| 2008 Q4 | 3.26 Million CAD | 21.81% |
| 2008 Q1 | 2.14 Million CAD | -4.19% |
| 2008 Q3 | 2.68 Million CAD | 26.78% |
| 2008 Q2 | 2.11 Million CAD | -1.25% |
| 2008 FY | 2.68 Million CAD | 22.05% |
| 2007 Q2 | 1.91 Million CAD | 27.23% |
| 2007 Q1 | 1.5 Million CAD | -36.41% |
| 2007 Q4 | 2.23 Million CAD | 1.74% |
| 2007 FY | 2.19 Million CAD | -7.8% |
| 2007 Q3 | 2.19 Million CAD | 14.99% |
| 2006 Q1 | 2.43 Million CAD | 9.89% |
| 2006 Q4 | 2.36 Million CAD | -0.89% |
| 2006 FY | 2.38 Million CAD | 15.24% |
| 2006 Q2 | 2.35 Million CAD | -3.57% |
| 2006 Q3 | 2.38 Million CAD | 1.45% |
| 2005 FY | 2.06 Million CAD | -13.13% |
| 2005 Q1 | 2.24 Million CAD | -3.15% |
| 2005 Q2 | 2.16 Million CAD | -3.36% |
| 2005 Q4 | 2.21 Million CAD | 7.2% |
| 2005 Q3 | 2.06 Million CAD | -4.61% |
| 2004 Q4 | 2.31 Million CAD | -2.69% |
| 2004 Q1 | 1.75 Million CAD | 25.74% |
| 2004 FY | 2.38 Million CAD | 74.42% |
| 2004 Q2 | 2.4 Million CAD | 36.92% |
| 2004 Q3 | 2.38 Million CAD | -0.88% |
| 2003 Q3 | 1.36 Million CAD | 11.3% |
| 2003 Q2 | 1.22 Million CAD | -6.13% |
| 2003 FY | 1.36 Million CAD | 7.25% |
| 2003 Q1 | 1.3 Million CAD | 23.19% |
| 2003 Q4 | 1.39 Million CAD | 2.21% |
| 2002 Q1 | 1.03 Million CAD | 9.02% |
| 2002 FY | 1.27 Million CAD | 52.07% |
| 2002 Q4 | 1.06 Million CAD | -16.68% |
| 2002 Q3 | 1.27 Million CAD | 33.38% |
| 2002 Q2 | 954.57 Thousand CAD | -7.61% |
| 2001 FY | 837.24 Thousand CAD | 36.11% |
| 2001 Q4 | 947.77 Thousand CAD | 0.0% |
| 2000 FY | 615.13 Thousand CAD | 10470.14% |
| 1999 FY | 5819.55 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | -148.533% |
| Axonics, Inc. | 82.35 Million USD | -65.486% |
| INVO Bioscience, Inc. | 19.99 Million USD | -581.637% |
| CVRx, Inc. | 39.28 Million USD | -246.96% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 38.895% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -4183.326% |
| MaxCyte, Inc. | 36.1 Million USD | -277.47% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -534.275% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -9.945% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1967.238% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -165.917% |
| Apyx Medical Corporation | 52.31 Million USD | -160.509% |
| Cutera, Inc. | 518.12 Million USD | 73.695% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -2451.348% |
| NeuroPace, Inc. | 86.99 Million USD | -56.664% |
| IRIDEX Corporation | 24.91 Million USD | -447.054% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -55.238% |
| enVVeno Medical Corporation | 2.43 Million USD | -5497.248% |
| TELA Bio, Inc. | 59.16 Million USD | -130.353% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 78.672% |
| UFP Technologies, Inc. | 118.04 Million USD | -15.459% |
| Modular Medical, Inc. | 2.27 Million USD | -5898.812% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -364.72% |
| LENSAR, Inc. | 22.4 Million USD | -508.207% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 93.788% |
| Surmodics, Inc. | 65.82 Million USD | -107.06% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -1220.797% |
| Inogen, Inc. | 121.38 Million USD | -12.284% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -8041.756% |
| RxSight, Inc. | 22.18 Million USD | -514.264% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -31947.752% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -360.745% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -489.146% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -31947.752% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -5510.382% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -30.293% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 80.626% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -435.259% |
| Dynatronics Corporation | 11.78 Million USD | -1056.975% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -163.812% |
| InMode Ltd. | 75.91 Million USD | -79.536% |
| Bruker Corporation | 2.83 Billion USD | 95.195% |
| Movano Inc. | 5.97 Million USD | -2182.2% |
| Orthofix Medical Inc. | 326.58 Million USD | 58.267% |
| FONAR Corporation | 57.45 Million USD | -137.206% |
| BioSig Technologies, Inc. | 4.68 Million USD | -2809.136% |
| Envoy Medical, Inc. | 9.4 Million USD | -1349.617% |
| Align Technology, Inc. | 2.45 Billion USD | 94.445% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -133.51% |
| Talis Biomedical Corporation | 29.22 Million USD | -366.374% |
| Cerus Corporation | 144.3 Million USD | 5.551% |
| 908 Devices Inc. | 37.49 Million USD | -263.545% |
| Nemaura Medical Inc. | 26.37 Million USD | -416.703% |
| Outset Medical, Inc. | 190.91 Million USD | 28.611% |
| NanoVibronix, Inc. | 2.68 Million USD | -4974.2% |
| Venus Concept Inc. | 107.1 Million USD | -27.254% |
| Telesis Bio, Inc. | 40.87 Million USD | -233.455% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -19.588% |
| IRadimed Corporation | 20.73 Million USD | -557.279% |
| Tenon Medical, Inc. | 5.56 Million USD | -2348.231% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3715.594% |
| Pulmonx Corporation | 60.63 Million USD | -124.772% |
| iCAD, Inc. | 8 Million USD | -1603.45% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -973.977% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -7275.522% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -234.131% |
| SI-BONE, Inc. | 61.05 Million USD | -123.248% |
| Semler Scientific, Inc. | 6.27 Million USD | -2073.732% |
| Biotricity, Inc. | 35.91 Million USD | -279.441% |
| Cytosorbents Corporation | 29.98 Million USD | -354.53% |
| DexCom, Inc. | 4.19 Billion USD | 96.752% |
| ZimVie Inc. | 795.85 Million USD | 82.875% |
| Aethlon Medical, Inc. | 2.47 Million USD | -5396.461% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -1039.757% |
| IceCure Medical Ltd | 4.24 Million USD | -3109.159% |
| PAVmed Inc | 57.13 Million USD | -138.537% |
| Sight Sciences, Inc. | 46.43 Million USD | -193.507% |
| Insulet Corporation | 1.85 Billion USD | 92.655% |
| Profound Medical Corp. | 12.66 Million USD | -976.066% |
| electroCore, Inc. | 8.94 Million USD | -1423.678% |
| Bioventus Inc. | 589.79 Million USD | 76.891% |
| InspireMD, Inc. | 8.14 Million USD | -1573.95% |
| PAVmed Inc. | 57.13 Million USD | -138.537% |
| Nuwellis, Inc. | 6.78 Million USD | -1910.221% |
| OrthoPediatrics Corp. | 72.56 Million USD | -87.832% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -1039.757% |
| BrainsWay Ltd. | 15.31 Million USD | -789.99% |
| BIOLASE, Inc. | 35.34 Million USD | -285.575% |
| Beyond Air, Inc. | 29.77 Million USD | -357.743% |
| AxoGen, Inc. | 101.16 Million USD | -34.727% |
| Inari Medical, Inc. | 209.32 Million USD | 34.889% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -6135.349% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -7561.214% |
| AdaptHealth Corp. | 3.15 Billion USD | 95.678% |
| Quanterix Corporation | 78.08 Million USD | -74.547% |
| Viveve Medical, Inc. | 10.84 Million USD | -1156.504% |
| LivaNova PLC | 1.15 Billion USD | 88.168% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -672.894% |
| Varex Imaging Corporation | 668.6 Million USD | 79.615% |
| Vivani Medical, Inc. | 25.03 Million USD | -444.388% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -3253.666% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3715.594% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -2690.031% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 86.954% |
| TransMedics Group, Inc. | 568.84 Million USD | 76.04% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -717.006% |
| NeuroMetrix, Inc. | 1.33 Million USD | -10123.58% |
| Spectral AI, Inc. | 12.4 Million USD | -999.048% |
| Hyperfine, Inc. | 9.8 Million USD | -1290.745% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 45.536% |
| Biomerica, Inc. | 2.66 Million USD | -5018.025% |
| Bone Biologics Corporation | 831.4 Thousand USD | -16293.153% |
| AVITA Medical, Inc. | 19.86 Million USD | -586.082% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -6805.516% |
| Silk Road Medical, Inc | 114.15 Million USD | -19.39% |